Cargando…
Anti-CD20 antibody induces the improvement of cytokine-induced killer cell activity via the STAT and MAPK/ERK signaling pathways
There is a current requirement for novel therapeutic strategies for the treatment of hematopoietic tumors. Residual tumor cells are the main origin of tumor relapse. The aim of this study was to eliminate the residual tumor cells of hematopoietic tumors. Cytokine-induced killer (CIK) cells are used...
Autores principales: | DENG, QI, BAI, XUE, LV, HAI-RONG, XIAO, XIA, ZHAO, MING-FENG, LI, YU-MING |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353788/ https://www.ncbi.nlm.nih.gov/pubmed/25780412 http://dx.doi.org/10.3892/etm.2015.2264 |
Ejemplares similares
-
Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies
por: Cappuzzello, Elisa, et al.
Publicado: (2016) -
Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis
por: Yuan, Xin, et al.
Publicado: (2021) -
MicroRNA profiling of CD3(+)CD56(+) cytokine-induced killer cells
por: Wang, Wenju, et al.
Publicado: (2015) -
PE-induced apoptosis in SMMC-7721 cells: Involvement of Erk and Stat signalling pathways
por: XUE, LI, et al.
Publicado: (2014) -
CMaf-Inducing Protein Promotes LUAD Proliferation and Metastasis by Activating the MAPK/ERK Pathway
por: Yu, Xiao-Yan, et al.
Publicado: (2022)